The present invention provides a method for the measurement of the activity of a plasminogen activator, such as urokinase plasminogen activator (uPA) or tissue plasminogen activator (tPA) in a biological sample using an assay method characterized by the inclusion of an elastase inhibitor in the assay mixture. The invention also provides a diagnostic kit for the measurement of a plasminogen activator using said method and a method of determining the effective therapeutic dose of a plasminogen activator inhibitor using said method. Also provided is a method of preparing a pharmaceutical composition.

 
Web www.patentalert.com

< Process for prophylaxis and therapy of thrombotic processes employing heparin having particular average molecular weights

< Hydrophilic member precursor and pattern forming material that utilizes it, support for planographic printing plate, and planographic printing plate precursor

> Indocyanine green (ICG) compositions and related methods of use

> Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
~ 00262